Premium
The ABSORB bioresorbable vascular scaffold: A novel, fully resorbable drug‐eluting stent: Current concepts and overview of clinical evidence
Author(s) -
Rizik David G.,
Hermiller James B.,
Kereiakes Dean J.
Publication year - 2015
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.26172
Subject(s) - medicine , bioresorbable scaffold , scaffold , stent , drug eluting stent , biomedical engineering , surgery , percutaneous coronary intervention , cardiology , restenosis , myocardial infarction
The advent of fully bioresorbable stent technology and specifically the ABSORB™, a bioresorbable vascular scaffold (BVS) stent, is heralded as breakthrough technology in the current era of percutaneous coronary interventions. This article reviews the current understanding of this technology along with the clinical evidence from trials and registries of ABSORB BVS that included patients with both simple as well as more complex “real‐world” coronary lesions. In addition, considering the current limitations of this device—mostly associated with the mechanical properties of the polymeric scaffold structure—a review of guidelines on successful implantation of the ABSORB BVS is presented. Although expert feedback suggests extensive use of this device in routine clinical practice outside the United States despite a paucity of data on long‐term safety in this setting, attention to procedural details and implantation technique is obligatory to achieve optimal clinical outcomes. © 2015 Wiley Periodicals, Inc.